Concentras Parent Debt to Equity Ratio 2025-2024 | CON
Current and historical debt to equity ratio values for Concentras Parent (CON) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Concentras Parent debt/equity for the three months ending June 30, 2024 was 0.00.
| Concentras Parent Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.956B | $1.838B |
| Concentra Group Holdings Parent Inc. is a provider of occupational health services principally in the United States. Concentra Group Holdings Parent Inc. is based in MECHANICSBURG, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $128.349B | 15.65 |
| Cencora (COR) | United States | $47.536B | 18.17 |
| ICON (ICLR) | Ireland | $24.384B | 21.91 |
| DiDi Global (DIDIY) | China | $18.907B | 0.00 |
| Avantor (AVTR) | United States | $18.492B | 28.04 |
| Natera (NTRA) | United States | $16.038B | 0.00 |
| Revvity (RVTY) | United States | $15.146B | 26.52 |
| Viatris (VTRS) | United States | $14.095B | 4.29 |
| CochLear (CHEOY) | Australia | $12.834B | 0.00 |
| Solventum (SOLV) | United States | $12.399B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.058B | 33.56 |
| Charles River Laboratories (CRL) | United States | $10.519B | 19.88 |
| Sonic Healthcare (SKHHY) | Australia | $8.839B | 0.00 |
| Doximity (DOCS) | United States | $7.322B | 46.40 |
| HealthEquity (HQY) | United States | $6.833B | 37.08 |
| Bausch + Lomb (BLCO) | Canada | $6.266B | 26.97 |
| PACS (PACS) | United States | $6.244B | 0.00 |
| Organon (OGN) | United States | $5.376B | 5.47 |
| Life Times (LTH) | United States | $4.877B | 40.77 |
| Sotera Health (SHC) | United States | $4.789B | 24.16 |
| Surgery Partners (SGRY) | United States | $4.050B | 44.87 |
| GoodRx Holdings (GDRX) | United States | $2.914B | 109.71 |
| Ardent Health Partners (ARDT) | United States | $2.506B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $2.387B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.202B | 0.00 |
| Progyny (PGNY) | United States | $2.195B | 38.59 |
| Premier (PINC) | United States | $2.080B | 9.35 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.023B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.751B | 8.79 |
| CareDx (CDNA) | United States | $1.568B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.397B | 0.00 |
| Agilon Health (AGL) | United States | $1.350B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.248B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.016B | 0.00 |
| Embecta (EMBC) | United States | $0.950B | 6.33 |
| QDM (QDMI) | Hong Kong, SAR China | $0.933B | 24.43 |
| Pediatrix Medical (MD) | United States | $0.923B | 10.05 |
| InnovAge Holding (INNV) | United States | $0.802B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.537B | 0.00 |
| Sharecare (SHCR) | United States | $0.521B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.492B | 0.00 |
| Enhabit (EHAB) | United States | $0.405B | 35.00 |
| Sonida Senior Living (SNDA) | United States | $0.373B | 0.00 |
| DocGo (DCGO) | United States | $0.372B | 14.00 |
| Biodesix (BDSX) | United States | $0.260B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.258B | 0.00 |
| LifeMD (LFMD) | United States | $0.221B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.204B | 0.00 |
| Beauty Health (SKIN) | United States | $0.185B | 0.00 |
| ModivCare (MODV) | United States | $0.181B | 5.76 |
| MultiPlan (MPLN) | United States | $0.153B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.083B | 20.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.082B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.057B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.69 |
| OncoCyte (OCX) | United States | $0.042B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.041B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.030B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.025B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.020B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| KindlyMD (KDLY) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |